Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The aim of this work is to evaluate Fibulin-1 (FBLN1) and serine threonine kinase-31 (STK31) as colorectal cancer (CRC) tumour markers and their ability to differentiate it from colorectal benign lesions.
|
29715435 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Fibulin-1 interacts with SHBG, it is associated with a less aggressive behavior of breast cancer cells and correlates to a better prognosis of the tumor.
|
29940241 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
When investigating the correlation between fibulin-1 expression and clinicopathological characteristics, we have found that low fibulin-1 protein expression was associated with poor tumor differentiation and advanced N stage.
|
26779638 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our results indicated that the FBLN1 gene may be a novel candidate of tumor suppressor gene in CRC, and that promoter hypermethylation of FBLN1 is an important reason for its downregulation and is also a good predictor of OS for CRC.
|
25837757 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In conclusion, our results indicated that FBLN1 is a novel candidate of tumor suppressor gene and that promoter hypermethylation of FBLN1 is associated with tumor progression in CM.
|
23907575 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Altogether, our results indicated that fibulin-1 expression is associated with NMIBC grade and recurrence, it is epigenetically down-regulated and functions as a tumor suppressor gene and angiogenesis inhibitor in bladder cancer.
|
25234557 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Fibulin-1 over expression led dramatically to decreased cell growth, enhanced tumor cell apoptosis, decreased cell motility and angiogenesis in cultured renal cell carcinoma cells and in xenograft tumors in nude mice.
|
23391467 |
2013 |
Neoplasms
|
0.100 |
PosttranslationalModification
|
group |
BEFREE |
Moreover, promoter hypermethylation of FBLN1 was significantly associated with advanced stage HCC, multiple tumors and increased tumor size.
|
21268132 |
2011 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
CD31 labeling and TUNEL assay further reveal that fibulin-1 suppression of HT1080 tumor growth is associated with diminished angiogenesis and also enhanced apoptosis of endothelial cells and tumor cells.
|
18222970 |
2008 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Doxorubicin was also found to augment tumor expression of the fibulin-1-binding proteins fibronectin and laminin-1.
|
17483339 |
2007 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Importantly, coexpression of fibulin-1 with GROalpha abrogates key aspects of the transformed phenotype, including tumor formation in a murine xenograft model.
|
17062666 |
2006 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Furthermore, even though long-term survival was similar between Fbln-1-positive and -negative cases, the survival of Fbln-1-positive cases improved when a lymphoid infiltrate was present at the tumour site.
|
14691454 |
2004 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Furthermore, the ratio of the 50 kDa fragment to the mature fibulin-1 polypeptide correlated with the level of oestrogen receptor alpha (Spearman correlation coefficient, rs=0.49, P<0.003, n=36) and progesterone receptor (rs=0.43, P=0.008, n=36) expression in the tumour specimens.
|
12644824 |
2003 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The differential expression of fibulin-1 between the normal tissues and breast carcinoma cell lines (5/6) and surgical specimens (5/6) suggests the possible involvement of the overexpression of this extracellular matrix-associated glycoprotein in the pathogenesis of this neoplasm.
|
12160330 |
2002 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The weak expression of fibulin-1 RNA in some stromal cells of these tumors could not explain the strong fibulin-1 protein accumulation in tumor stroma, which was therefore mostly produced by tumor epithelial cells.
|
9811350 |
1998 |